NEW YORK, NY / ACCESS Newswire / June 3, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151500&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / June 3, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=151499&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / June 3, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151498&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at

NEW YORK, NY / ACCESS Newswire / June 3, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151496&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / June 3, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=151495&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nike-themed non-fungible tokens ("The Nike NFTs"), crypto collectibles, or other crypto assets issued by RTFKT, Inc. ("RTFKT"). Class Definition This lawsuit seeks

PrairieSky Royalty Declares Quarterly Dividend GlobeNewswire June 03, 2025 CALGARY, Alberta, June 03, 2025 (GLOBE NEWSWIRE) — PrairieSky Royalty Ltd. (“PrairieSky”) (TSX:PSK) announced today that its Board of Directors has declared a quarterly dividend of CDN $0.26 per common share, payable in cash on July 15, 2025 to shareholders of record on June 30, 2025.

(NasdaqGM:XENE), VANCOUVER, British Columbia and BOSTON, June 03, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced that the company will present at the Goldman Sachs 46th Annual Global Healthcare Conference taking place in Miami, FL, from

(NASDAQ:HQY), Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25. Net income of $53.9 million, an increase of 87% compared to $28.8 million in Q1 FY25, with non-GAAP net income of $85.8 million, an increase of 22% compared to $70.3 million in Q1

(TSX:PSK), CALGARY, Alberta, June 03, 2025 (GLOBE NEWSWIRE) — PrairieSky Royalty Ltd. (“PrairieSky”) (TSX:PSK) announced today that its Board of Directors has declared a quarterly dividend of CDN $0.26 per common share, payable in cash on July 15, 2025 to shareholders of record on June 30, 2025. This dividend is designated as an “eligible dividend”